LRRK2 is a kinase mutated in Parkinson's disease, but how the protein affects synaptic function remains enigmatic. We identified LRRK2 as a critical regulator of EndophilinA. Using genetic and biochemical studies involving Lrrk loss-of-function mutants and Parkinson-related LRRK2 G2019S gain-of-kinase function, we show that LRRK2 affects synaptic endocytosis by phosphorylating EndoA at S75, a residue in the BAR domain. We show that LRRK2-mediated EndoA phosphorylation has profound effects on EndoA-dependent membrane tubulation and membrane association in vitro and in vivo and on synaptic vesicle endocytosis at Drosophila neuromuscular junctions in vivo. Our work uncovers a regulatory mechanism that indicates that reduced LRRK2 kinase activity facilitates EndoA membrane association, while increased kinase activity inhibits membrane association. Consequently, both too much and too little LRRK2-dependent EndoA phosphorylation impedes synaptic endocytosis, and we propose a model in which LRRK2 kinase activity is part of an EndoA phosphorylation cycle that facilitates efficient vesicle formation at synapses.
INTRODUCTION
Imbalances in synaptic transmission have been implicated in Parkinson's disease (PD) (Esposito et al., 2012; Plowey and Chu, 2011) ; however, the underlying molecular mechanisms remain unexplained. EndophilinA (EndoA) is an evolutionary conserved protein critically involved in synaptic vesicle endocytosis (Ringstad et al., 1997) . EndoA harbors a Bin/Amphiphysin/ Rvs (BAR) domain that interacts with membranes and contains special helices that, upon membrane insertion, are thought to induce membrane deformation (Farsad et al., 2001; Gallop et al., 2006) . In vitro, EndoA tubulates membranes, while in vivo EndoA is thought to drive vesicle formation by sensing or inducing membrane curvature (Gallop et al., 2006; Masuda et al., 2006) and facilitating vesicle uncoating (Milosevic et al., 2011; Verstreken et al., 2002) . Consequently, loss of EndoA function results in very severe defects in synaptic vesicle endocytosis in different species (Gad et al., 2000; Milosevic et al., 2011; Schuske et al., 2003; Verstreken et al., 2002) . Thus, EndoA is a critical component of the endocytic machinery and is therefore ideally posed to serve as a regulatory hub in the endocytic process.
Here we identify EndophilinA as a substrate of leucine-rich repeat kinase 2 (LRRK2), a protein mutated in PD, and we show that EndoAS75 phosphorylation is increased when expressing the kinase-active clinical mutant LRRK2 G2019S (Paisá n-Ruíz et al., 2004; Zimprich et al., 2004) and strongly decreased in Lrrk mutants (Lee et al., 2007) . Increased EndoAS75 phosphorylation inhibits EndoA-dependent membrane tubulation and decreases EndoA membrane affinity in vitro and in vivo. In addition, expression of phosphomimetic EndoA or expression of LRRK2 G2019S impedes synaptic endocytosis. Conversely, reduced EndoAS75 phosphorylation in Lrrk mutants increases EndoA membrane affinity, and expressing phosphodead EndoA or Lrrk mutations also inhibits endocytosis, a defect rescued by heterozygous endoA. Consistently, at moderate concentrations, the LRRK2 kinase-inhibitor LRRK2-IN1 restores endocytosis in LRRK2 G2019S -expressing animals, while at higher concentrations it blocks endocytosis to the level seen in Lrrk mutants. Thus, LRRK-dependent EndoAS75 phosphorylation regulates EndoA membrane affinity and both increased and decreased LRRK2 kinase activity inhibits synaptic endocytosis.
RESULTS

Slowed Synaptic Vesicle Endocytosis in Lrrk Mutants
Drosophila LRRK is present at synapses and associates with membranes and based on knockdown experiments in hippocampal neurons, LRRK2 has been implicated in regulating synaptic vesicle trafficking (Piccoli et al., 2011; Shin et al., 2008) . To determine whether, in Drosophila, LRRK is involved in synaptic vesicle endocytosis, we measured neurotransmitter release in high external calcium using currentclamp recordings at third-instar larval neuromuscular junctions (NMJs) in Lrrk loss-of-function mutants (Lee et al., 2007) . While the amplitude of the excitatory junctional potential (EJP) recorded from Lrrk mutants at low-frequency stimulation in 2 mM external calcium does not show a difference compared to controls (see Figure S1A available online), Lrrk mutants fail to maintain release during intense (10 Hz) stimulation in 2 mM calcium, a defect often observed in mutants with reduced synaptic vesicle endocytosis (Figures 1A and 1B) .
Testing further for a defect in synaptic vesicle formation in Lrrk mutants, we used FM1-43 labeling at third-instar NMJs. FM1-43 is a lipophilic dye that becomes fluorescent when inserted in the membrane and is internalized into newly formed synaptic vesicles upon nerve stimulation. Using different stimulation paradigms in the presence of FM1-43, Lrrk mutants show reduced dye uptake compared to controls ( Figures 1C-1F ). This defect is not caused by reduced vesicle fusion during stimulation, as FM1-43 loaded during a 5 min, 90 mM KCl stimulation paradigm is unloaded as efficiently from Lrrk mutant boutons as it is from control boutons when stimulated using either 90 mM KCl (Figure 1G) or 10 Hz nerve stimulation ( Figure S1B ; rate constant, control: 0.430 ± 0.058 min À1 ; Lrrk: 0.509 ± 0.064 min À1 ), again indicating that, under these conditions, vesicle fusion per se is not majorly affected in Lrrk mutants. The defect in FM1-43 internalization is also not caused by major morphological changes at the NMJ, as synapse length and large type 1b bouton number are not affected in Lrrk mutants compared to controls (Figures S1C and S1D). Finally, the defect in FM1-43 internalization is also specific to loss of Lrrk function, as a different heteroallelic combination (Lrrk
P1 /Lrrk
EX2
) displays an identical defect to internalize FM1-43 compared to Lrrk P1 ( Figure 1D ), and furthermore, expression of human LRRK2 in Lrrk P1 mutants rescues the FM1-43 dye uptake phenotype ( Figure 1E ), indicating evolutionary conservation of this function of LRRK2.
To also assess the ultrastructure of Lrrk mutant boutons, we performed transmission electron microscopy (TEM) of stimulated NMJ boutons. In contrast to control boutons, we observe an increased density of cisternal structures and larger vesicles at the expense of normal-sized synaptic vesicles in Lrrk mutant boutons ( Figures 1H-1L ). Our data also suggest these cisternae in Lrrk mutants can fuse with the membrane and release transmitters, as miniature EJP (mEJP) amplitude in Lrrk mutants is markedly increased compared to controls Figure S1E) . Larger amplitude mEJPs may be due to more neurotransmitters being released from presynaptic vesicles or also because of a more elaborate glutamate receptor field; however, the postsynaptic glutamate receptor field in Lrrk mutants does not appear different from controls at the level of immunohistochemistry ( Figure S1F ), suggesting that the defect in mEJP amplitude in Lrrk mutants originates presynaptically. An increased number of cisternae are often observed in mild endocytic mutants, including hypomorphic endophilinA (endoA) (Guichet et al., 2002) , dap160 (Koh et al., 2004) , AP180/lap (Zhang et al., 1998) , eps15 (Koh et al., 2007) , and stnB (Fergestad et al., 1999) mutants. The cisternal defect is thought to arise from a slowed and inefficient endocytic machine that fails to form vesicles of defined size. Hence, the data are consistent with slowed synaptic vesicle recycling in Lrrk mutants.
Lrrk Mutants Are Rescued by Heterozygous endoA To start exploring the potential function for LRRK in vesicle recycling, we quantified synaptic vesicle formation in Lrrk mutants heterozygous for different components involved in clathrinmediated synaptic vesicle endocytosis. While heterozygosity for clathrin heavy chain (chc), AP180 (lap), alpha adaptin (a-ada), eps-15, and dap160/intersectin (dap160) in Lrrk mutants does not affect FM1-43 dye uptake, loss of one copy of endoA in Lrrk mutants completely rescues the FM1-43 dye uptake defect observed in Lrrk mutants back to control levels ( Figure 2A ). This effect is specific to the loss of one copy of endoA, because crossing a genomic rescue construct that expresses the wildtype endoA gene (endoA + ) at endogenous levels, into Lrrk mutants that are heterozygous mutant for endoA, shows FM1-43 dye uptake defects akin to Lrrk mutants ( Figure 2A ). In contrast to loss of endoA rescuing the endocytic defect in Lrrk mutants, overexpressing EndoA using an upstream activating sequence (UAS)-EndoA transgene (Jung et al., 2010) and the Elav-Gal4 neuronal driver in Lrrk mutants exacerbates the FM1-43 dye uptake defect that we observed in Lrrk mutants (Figure 2B) . Note that overexpression of EndoA alone does not show a defect in FM1-43 dye uptake. Thus, EndoA is a dosage-sensitive modifier of Lrrk in Drosophila.
To further test the effect of endoA on the suppression of Lrrkdependent phenotypes, we also measured neurotransmitter release during 10 Hz stimulation in Lrrk mutants that are heterozygous for endoA. We find that Lrrk mutants with only one copy of endoA are very similar to controls in this assay ( Figure 2C ). Finally, we also measured the ability of Lrrk mutants and Lrrk mutants heterozygous for endoA to resist stress at high temperature. In this assay, we placed the flies in a tube in a water bath at 38 C and counted the flies climbing on the wall within a 1 hr time interval. Lrrk mutant flies drop faster than controls, and also this defect is rescued by heterozygous endoA. Again, crossing endoA + into Lrrk mutants that are heterozygous mutant for endoA shows a defect very similar to Lrrk ( Figure S2 ). Hence, heterozygous loss of endoA suppresses numerous deficits observed in Lrrk mutants.
LRRK2 Phosphorylates EndoA at Serine 75
Given the genetic interaction between Lrrk and endoA, we tested whether human LRRK2 or Drosophila LRRK can phosphorylate EndoA in vitro using purified proteins in a 33 P-ATP phosphorylation assay. Incubation of human LRRK2 with human EndoA1-EndoA3 indicates efficient EndoA1-EndoA3 phosphorylation by LRRK2 ( Figures 3A-3C 0 ). Adding kinase-hyperactive clinical LRRK2 G2019S mutant results in faster and more efficient EndoA1 phosphorylation, while adding kinase-dead mutant LRRK2 does not show appreciable EndoA1-EndoA3 phosphorylation. Similarly, a Drosophila LRRK-enriched fraction, as well as human LRRK2 and LRRK2G2019S, is able to efficiently phosphorylate tandem affinity-purified Drosophila Flag-strep-EndoA. In contrast, a kinase-dead LRRK2KD is not able to phosphorylate tandem affinity-purified Drosophila Flag-strep-EndoA ( Figure 3D , Figure S3C ). Conversely, another Parkinson's disease-related kinase, GSK3b , is not able to phosphorylate EndoA1 in vitro (data not shown). Thus, the data indicate that EndoA is a target of LRRK and LRRK2 kinase activity in vitro.
To identify the EndoA1 amino acid(s) targeted by LRRK2 activity, we used mass spectrometry (MS). In vitro phosphorylated EndoA1 was separated from other proteins by SDS-PAGE and the EndoA1 band was in-gel digested with trypsin. Samples were then separated using liquid chromatography and spectra obtained via an Orbitrap MS/MS were identified with the MASCOT search algorithm in the SwissProt database. At 86% EndoA1 sequence coverage ( Figure S3A ), our analyses identified one conserved site, serine 75 (S75) at 99% confidence, as a target of LRRK2-dependent phosphorylation. Also after independent enrichment of phosphopeptides using titanium dioxide, we identified S75 as an LRRK2 phosphorylation site. This site is specific, as we did not identify S75 to be phosphorylated when incubating EndoA with LRRK2 KD ( Figure S3B ). EndoA1 S75 is well conserved across species ( Figure 3E) (Kjaerulff et al., 2011) , and to determine the contribution of LRRK2 to the basal EndoA1 phosphorylation level, we generated a stably transfected LRRK2 shRNA-expressing CHO cell line with strongly reduced LRRK2 expression levels (Figures S4A and S4B) . We find that in these shRNA-expressing cells, EndoA1 phosphorylation is reduced to a level significantly lower than the basal level of EndoA1 phosphorylation. Similarly, LRRK2 shRNA also efficiently knocks down coexpressed LRRK2 G2019S (or LRRK2 KD ) ( Figures S4C and S4D Figure 4C ). Next, we tested Lrrk mutant and control Drosophila extracts and probed western blots with Ab-Endo S75 and Ab-EndoA GP69 that recognize Drosophila EndoA (Verstreken et al., 2002 /+;Lrrk P1 in E) NMJ boutons in L3 fillets using 1 min, 90 mM KCl stimulation to label the exo-endo cycling pool (ECP) (C-E) or using a protocol that labels the reserve pool (RP) (F); FM1-43 loading in 10 min of 10 Hz stimulation in 2 mM Ca
2+
; 5 min no stimulation; wash in HL-3 and unload ECP using 5 min, 90 mM KCl without FM1-43. Error bars represent SEM. n > 9, t test: **p < 0.01; ***p < 0.001. (G) Quantification of FM1-43 labeling intensity after a loading and unloading protocol of control and Lrrk P1 mutant synapses. NMJs were loaded using 5 min, 90 mM KCl in FM1-43, washed, and imaged and then unloaded using 1 min, 90 mM KCl in the absence of FM1-43, washed, and imaged again. The percent dye loss compared to the labeled boutons is shown. An unloading time course is shown in Figure S1 . Error bars represent SEM, n > 5, t test: ns, not significant. 0 ), suggesting that phosphorylation of S75 inhibits membrane tubulation in vitro. To determine whether this effect is due to LRRK2-dependent phosphorylation, we phosphorylated EndoA in vitro using LRRK2 and ATP and then incubated the proteins with GUVs. In contrast to nonphosphorylated EndoA, LRRK2-phosphorylated EndoA does not induce GUV tubulation (Figures 5E, 5F, and 5K 00 ). This effect is specific to LRRK2-dependent EndoA phosphorylation at S75, because incubation of GUVs with phosphodead EndoA[S75A] that was treated with LRRK2 and ATP results in efficient tubulation (Figures 5G and 5K 00 ). These data indicate that LRRK2-dependent EndoA S75 phosphorylation inhibits membrane tubulation in vitro.
To understand the functional significance of EndoA S75 phosphorylation, we modeled the three-dimensional structure of Drosophila EndoA using the X-ray crystal coordinates of human EndoA (Weissenhorn, 2005 ) (PDB2Z0V). Interestingly, Drosophila EndoA S75 is located in the BAR domain at the tip of the helix1 appendage and we propose that, similar to mammalian EndoA1 (Jao et al., 2010) , EndoA S75 also associates with the membrane (Figures 5I and 5J ). Given that phosphorylation at S75 introduces a negative charge, we tested whether this modification affects membrane association of EndoA using liposome flotation assays (Figures 5K 0 and 5L Figure 5K 00 ). Thus, phosphorylation of EndoA at S75 is an important determinant of EndoA membrane association in vitro.
Finally, we tested whether LRRK2 can influence membrane association of EndoA that is already bound to liposomes. We therefore preincubated EndoA with liposomes and only Error bars represent SEM, n = 3 independent experiments and data means fitted using GraphPad.
(E) Alignment of human, mouse EndoA1, EndoA2, and EndoA3, nematode UNC-57, and fruit fly EndoA around the S75 phosphorylation site (red) identified by mass spectrometry. Related to Figure S3 . present in the membrane fraction compared to cells expressing kinase-dead LRRK2 KD ( Figures S5C and S5D) . Thus, in line with our in vitro results, both in flies and in mammalian cells, loss of Lrrk/LRRK2 function results in increased association of EndoA with membrane, whereas gain-of-LRRK2 kinase activity impedes EndoA membrane association.
Phosphodead and Phosphomimetic EndoA Inhibit Endocytosis
Our results thus far allow us to make a number of predictions. First, given that inhibition of EndoA S75 phosphorylation facilitates membrane association, we expect flies expressing a phosphodead EndoA to harbor too much membrane-bound EndoA that impedes the endocytic process, similar to our observations in Lrrk mutants. Second, phosphorylation of EndoA S75 inhibits membrane association of the protein and flies expressing a phosphomimetic EndoA are therefore predicted to also show reduced endocytosis. Third, because EndoA S75 phosphorylation in animals that express the kinase-active LRRK2 G2019S is increased, we also expect this condition to show reduced endocytosis. Fourth, we surmise that a specific LRRK2 kinase inhibitor will result in endocytic defects similar to Lrrk mutants and that this inhibitor does not exacerbate the endocytic defects in phosphodead EndoA but that it rescues the endocytic defects in LRRK2 G2019S -expressing animals.
To start testing these predictions, we expressed EndoA [S75A] and EndoA[S75D] using genomic fragments in endoA D4 null mutants ( Figure S6A) Figures 7A-7D ). Our data indicate that both phosphorylation and dephosphorylation of EndoA at S75 inhibit FM1-43 dye uptake at synapses in vivo.
To further test our predictions, we also used an independent pharmacological approach to inactivate LRRK2 activity. We incubated dissected control third-instar larval fillets for 30 min with different concentrations of LRRK2-IN-1, an LRRK2 inhibitor (Deng et al., 2011) , and determined synaptic endocytosis using FM1-43. Application of LRRK2-IN-1 results in a dose-dependent ) and ATP (M and K 00 0 , right column). EndoA was detected using Ab-FlagM2. Binding percentage right column in (K) was quantified as the intensity in the top two fractions (1 and 2) compared to the total labeling in all fractions (1-6). n = at least 3 independent blind repeats.
reduction in FM1-43 dye uptake (Figure S6B) . Furthermore, defects in FM1-43 dye uptake are very similar in Lrrk mutants or in Lrrk mutants incubated with the inhibitor (Figure S6C ), indicating specificity of LRRK2-IN-1 to LRRKdependent synaptic membrane uptake defects. In addition, LRRK2-IN-1-mediated inhibition of LRRK in animals that only express the phosphodead EndoA does not significantly exacerbate their FM1-43 dye uptake defect ( Figure S6D ). Hence, reduced LRRK-dependent EndoA S75 phosphorylation results in reduced synaptic vesicle formation during stimulation. A high concentration of inhibitor is needed in these assays probably because of limited penetration into the Drosophila larval NMJ (Mi skiewicz et al., 2011; Pawlu et al., 2004) . It should be noted that the specificity of the effect is controlled in Figures S6C  and S6D , demonstrating that the defect in synaptic endocytosis is critically dependent on the absence of LRRK and on the ability of EndoA to be phosphorylated.
To assess whether the defects in FM1-43 dye uptake in the EndoA S75 phosphomutants are the result of reduced synaptic vesicle endocytosis, we recorded EJPs during a 10 min of 10 Hz stimulation paradigm; we analyzed boutonic ultrastructure and we recorded mEJPs, assays that when performed on Lrrk mutants show defects (Figure 1) Figure 7K and Figure S6G ). These defects are qualitatively similar to those observed in Lrrk mutants ( Figure 1 ) and collectively they suggest that animals expressing the EndoA S75 phosphomutants harbor synaptic vesicle recycling deficits that parallel the endocytic defect seen in endoA hypomorphic mutants (Guichet et al., 2002 Figure 8B ). Taken together, the data indicate that both increased and decreased LRRK-dependent EndoA phosphorylation impedes synaptic vesicle endocytosis ( Figures 8C and 8D ).
DISCUSSION
In this work, we show that EndoA is phosphorylated by LRRK2 and that this posttranslational modification modulates EndoAdependent membrane deformation in vitro and endocytosis of synaptic membrane in vivo. Endocytosis is a dynamic process that depends on numerous transient protein-protein and protein-lipid interactions (Schmid et al., 2006; Tonikian et al., 2009) . Our data indicate that reduced S75 phosphorylation in EndoA, although still supporting membrane tubulation in vitro, acts negatively on synaptic recycling in vivo, because the protein fails to efficiently leave the membrane ( Figure 8D ). In line with this, a constitutive membrane-bound EndoA (Unc-57) also does not fully rescue unc-57 C. elegans mutants (Bai , and Ab-Nsyb R29 revealing EndoA partitioning between membrane (D) and cytosol (E) and quantification of the ratio of labeling intensity of Ab-EndoA GP69 in the membrane fraction normalized to Ab-Nsyb R29 to the labeling intensity of Ab-EndoA GP69 in the cytosol fraction normalized to Ab-Tubulin, normalized to control (F). Error bars represent SEM, n = 4 independent experiments. ANOVA and Dunnett's post hoc: **p < 0.05. Related to Figure S5 . et al., 2010) . In addition, overexpression of EndoA in Lrrk mutants exacerbates synaptic vesicle endocytosis, while heterozygous loss of endoA rescues Lrrk mutants. The data suggest that excessive dephosphorylated EndoA in Lrrk flies is ''locked'' such that constitutive membrane binding of the protein impedes the transient and vibrant interactions needed to create new vesicles and/or to deliver the protein to endocytic zones (Bai et al., 2010) . EndoA is also involved in recruiting Synaptojanin (Synj) to nascent synaptic vesicles. Synj is a phosphoinositide phosphatase involved in uncoating of proteins from newly formed vesicles, and endoA null mutant synapses display reduced levels of Synj and an increased number of densely coated synaptic vesicles (Milosevic et al., 2011; Schuske et al., 2003; Verstreken et al., 2002) . Given that it is difficult to discern coated from uncoated vesicles in our TEM preparations of the EndoA S75 phosphomutants, we did not determine whether the amount of densely coated vesicles is altered. However, we observe reduced levels of the uncoating factor Synaptojanin in Lrrk animals (unpublished data), suggesting that in the Lrrk flies late stages of endocytosis may also be blocked. Further work is needed to determine precisely how different aspects of EndoA function are affected by LRRK. Nevertheless, LRRK-dependent phosphorylation of EndoA in the helix1 appendage reduces EndoA membrane affinity and this modification may force the protein to leave nascent uncoated vesicles, driving new vesicle formation ( Figure 8C ). Indeed, LRRK2 kinase is able to dissociate EndoA from liposomes and we propose a model in which an S75 phosphorylation-dephosphorylation cycle controls EndoA function at the membrane to drive vesicle formation and uncoating at the synapse (Figures 8C and 8D) . Conceivably, LRRK is involved in the efficient removal of postendocytic EndoA and its binding partners from synaptic vesicles, allowing a new round of endocytosis to occur.
Mutations in the LRRK2 gene are the leading cause of familial PD, but the molecular mechanisms by which the gene impacts on neuronal function and survival remain obscure (Cookson, 2010) . We find a role for LRRK at the synapse, and our work now provides evidence that EndoA is a direct target of LRRK2 kinase activity. LRRK2 mutations cause late onset (>50 years of age) PD (Paisá n- Ruíz et al., 2004; Zimprich et al., 2004) and this is consistent with the mild defects in neuronal function we observe in Lrrk mutants or in preparations treated with a selective LRRK2 inhibitor (LRRK2-IN-1) . Furthermore, our data indicate that phosphorylation of EndoA at S75 is not absolutely essential for synaptic vesicle endocytosis but modulates the process. From a disease point of view, we demonstrate that the most frequent genetic mutation associated with PD LRRK2 G2019S (Correia Guedes et al., 2010) increases EndoA phosphorylation at S75. In agreement with our hypothesis that both gain and loss of phosphorylation at this site will lead to functional defects, expression of LRRK2 G2019S leads to a moderate but consistent defect in synaptic recycling. While the primary goal of our work was to clarify the physiological role of LRRK/LRRK2 in synaptic function, it is tempting to speculate that chronic deregulation of such a relative mild mechanism caused by either gain or loss of function of LRRK2 might underlie a slowly progressing and age-dependent disease such as PD. Kinase activating LRRK2 mutations but also numerous LRRK2 mutations of which the molecular effect remains unexplained have been implicated in PD (Greggio and Cookson, 2009 ). Our work indicates that both excessive phosphorylation and an inability to phosphorylate EndoA at S75 impede synaptic endocytosis, suggesting that deregulation of LRRK2 in different ways may all result in similar reduced endocytic function. Interestingly, recent data from endoA knockout mice indicate that loss of the gene causes neurodegeneration (Milosevic et al., 2011) , further linking the LRRK2-induced defects at the level of EndoA to a neurodegenerative disorder like PD. Our data also lead to the important conclusion that both gain and loss of LRRK2 activity has to be taken into consideration when developing LRRK2 as a drug target for PD, and careful titration of LRRK2 inhibitors might be needed to find a therapeutic window.
EXPERIMENTAL PROCEDURES
Drosophila Genetics Lrrk P1 [e03680] and Lrrk EX2 mutants were gifted by Jongkyeong Chung (KAIST) (Lee et al., 2007) . Controls were w 1118 , unless otherwise indicated.
Other alleles were the following: w; endoA D4 (Verstreken et al., 2002) , w chc 1 (Bazinet et al., 1993) , w; dap160 D2 (Koh et al., 2004) , lap 1 (Zhang et al., 1998) , yw; eps15 e75 (Koh et al., 2007) , and w; a-ada 1 (Gonzá lez-Gaitá n and Jä ckle, 1997). endoA + in Figure 2 is endo + (21B) (Venken et al., 2008) . Genomic EndoA phosphomutants were generated by chimeric PCR using endo + (21B) in P(acman) and primers in ), and LRRK2 G2019S were generated by site-directed mutagenesis using pCDNA3.1 LRRK2V5 and primers in Table S1 . These constructs were cloned into pUAST-attB using XhoI and NotI. Transgenes were inserted into VK22 on the second chromosome.
Microscopy FM1-43, electrophysiology, and electron microscopy were performed and the data quantified as described (Uytterhoeven et al., 2011; Mi skiewicz et al., 2011) and as outlined in the Supplemental Experimental Procedures. Antibodies used were the following: anti-HRP rabbit pAb (1:1,000; Jackson ImmunoResearch), anti-Dlg 4F3 mouse mAb (1:50), anti-GluRIIA 8B4D2 mouse mAb (1:50, DSHB), anti-endophilin Ab-EndoA GP69 guinea pig (1:1,000), and Alexa-conjugated secondary antibodies (Invitrogen).
Mass Spectrometry
Cold in vitro LRRK2-phosphorylated human EndoA1 was separated by SDS-PAGE and Coomassie-stained bands were excised and in-gel digested with trypsin. One part was analyzed by LC-MS/MS using an Orbitrap XL MS (Ghesquiè re et al., 2009); a second part was used to isolate phosphopeptides by titanium dioxide beads (GE Healthcare, TiO 2 Mag Sepharose). MASCOT generic files from the LC-MS/MS data were used to search the human Swiss-Prot database with trypsin as the protease, allowing for one missed cleavage. Mass tolerance of the precursor ions was set to 10 ppm (with MASCOT's C13 option set to 1) and of fragment ions to 0.5 Da. Variable modifications were as follows: N-acetylation, N-pyroglutamate, oxidation of methionine, phosphorylation of serine, threonine, and tyrosine and propionamide formation of cysteine. Only peptides ranked first, and those of which the MASCOT ion score exceeded the corresponding identity threshold score set at the 99% confidence level were withheld. A total of four in vitro human EndoA preparations with LRRK2 and four with LRRK2 KD were analyzed by LC-MS/MS, and, for one preparation, an in-gel N-propionylation step was done (Arnesen et al., 2010) . Drosophila EndoA Serine 75 Phosphoantibodies Rabbit EndoA S75 phosphoantibodies were generated at Pickcell against VKGI ph SKLSGQA and affinity purified using the same peptide and the nonphosphopeptide. For lambda phosphatase, fly heads were collected on ice and crushed in lysis buffer (10 mM HEPES, 150 mM NaCl, 1% triton) (pH 7.4) with complete protease inhibitor (Roche). Lysate was cleared at 10,000 3 g for 10 min and supernatant incubated with 800 units/100 mg lambda phosphatase for 1 hr at 30 C.
Tubulation and Flotation Assays
GUVs were composed of a 5:2:1:1 molar ratio of brain L-a-phosphatidylcholine, L-a-phosphatidylethanolamine, L-a-phosphatidylserine, cholesterol (Avanti Polar Lipids), and 2 mol% DiO (Invitrogen). We dried 1 ml of 1 mg/ml lipid in chloroform at 70 C followed by passive rehydration in PBS with 3 ng/ml EndoA (or mutant EndoA) (van den Bogaart et al., 2007) ; fly EndoA was prepared as outlined in the Supplemental Experimental Procedures. Blinded confocal microscopy was used to determine tubulation (Yoon et al., 2010) . GUVs prepared by electroswelling (data not shown) yielded similar results. Liposome composition in flotations (Schuette et al., 2004 ) was identical to GUVs. We loaded 30 mM lipids in 25 ml HP150 buffer (20 mM HEPES [pH 7.4]; 150 mM KCl) and 3% (w/v) Na-cholate on a sephadex-G50 (SigmaAldrich) column. We formed $35-nm-sized liposomes by size exclusion chomatography (van den Bogaart et al., 2010) . Liposome concentration was 240 nM (by FCS; Cypionka et al., 2009) . We mixed 750 nM EndoA with two volumes of liposome suspension and 40% (w/v) nycodenz (Axis-Shield; also in HP150), overlaid with 30% (w/v) nycodenz and HP150, and centrifuged for 3 hr at 259,000 3 g in a swinging bucket. We retrieved 20 ml fractions for western blotting.
LRRK2 phosphorylation in the presence of liposomes was prepared in kinase buffer (50 mM Tris [pH 7.5], 1 mM EGTA, 10 mM MgCl 2 , 2 mM DTT; no detergents) and 2 mM total lipids with 250 nM EndoA were Dunnett's post hoc: *p < 0.05; ***p < 0.001. Scale bar represents 4.5 mm. The dotted line indicates FM1-43 uptake in Lrrk P1 mutants (shown in Figure 1 ). Related to Figure S6 . Figure S6 ) and unloading of FM1-43 during a 1 min, 90 mM KCl stimulation paradigm is also similar in the control and the EndoA phosphomutants ( Figure S6 ) and mEJP sample traces. n > 8 animals, t test: *p < 0.05. Related to Figure S6 .
preincubated and then mixed with 1 ng/ml LRRK2 G2019S or kinase-dead LRRK2 KD (LRRK2 D1994A ) and 200 mM ATP for 2 hr at 37 C. This reaction was mixed with nycodenz and centrifuged.
Western Blotting
Fly heads collected on ice were crushed in lysis buffer (10 mM HEPES, 150 mM NaCl, 1% triton) (pH 7.4) with complete protease (Roche) and phosphatase inhibitor cocktail 2 and 3 (Sigma) followed by clearing at 10,000 3 g for 10 min. Proteins separated on Bis-Tris 4%-12% precast gels (Life Technologies) were transferred to nitrocellulose. Primary antibodies were the following: Ab-EndoA GP69 guinea pig (1:5,000); Ab-EndoA S75 rabbit (1:200); Ab-Nsyb R29 rat (1:2,000); anti-ATPA1 (Novus Biologicals); anti-Flag M2 (Sigma); and antialpha Tubulin (1:2,000). ]; Life Technologies). After 24 hr, cells were incubated for 2 hr in phosphate-free medium (MP Biomedicals). Intracellular ATP was labeled by 33 P orthophosphoric acid (400 mCi/well) (Perkin Elmer) in phosphate-free medium. Washed and lysed cells (1 min sonication) were centrifuged (10 min at 10,000 3 g) and supernatant was precleared (Dynabeads, Invitrogen). EndoA was immunoprecipitated using anti-Flag antibodies (Sigma) and analyzed on 4%-12% SDS-PAGE using phosphoimaging (Typhoon, GE Healthcare).
In Vitro and Cellular Phosphorylation
Fractionations
We collected 150 fly heads or 500,000 cells on ice and homogenized (1,000 rpm) them in STE (5 mM Tris, 250 mM sucrose, 1 mM EGTA) (pH 7.4) with complete protease (Roche) and phosphatase inhibitor cocktail 2 and 3 (Sigma). Lysate was centrifuged (10 min at 1,000 3 g) and supernatant centrifuged at 55,000 3 g for 1 hr. Supernatant (cytoplasm) was collected and pellet (membranes) were dissolved in STE with 0.5% triton. Equal amounts of protein from each fraction were analyzed by western blotting.
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